Molecular Haemato-Oncology at Bristol Genetics Laboratory Kayleigh Templeman .
. Cytogentic & Molecular Risk Stratification based management of Pediatric AML in 2015 Brijesh Arora, Professor, Division of Pediatric Oncology, Tata Memorial.
Should complete remission, however strictly defined, be the goal for everyone? YES! New York, October 23, 2014 Ola Landgren, M.D., Ph.D. Chief, Myeloma.
